The global burden of asthma: executive summary of the GINA Dissemination Committee report M Masoli, D Fabian, S Holt, R Beasley, ... Allergy 59 (5), 469-478, 2004 | 5625 | 2004 |
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2183 | 2019 |
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 523 | 2019 |
Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysisCommentary: Dosage needs systematic and critical review S Holt, A Herxheimer, A Suder, M Weatherall, S Cheng, P Shirtcliffe, ... Bmj 323 (7307), 253, 2001 | 291 | 2001 |
Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial M Patel, J Pilcher, A Pritchard, K Perrin, J Travers, D Shaw, S Holt, ... The Lancet Respiratory Medicine 1 (1), 32-42, 2013 | 230 | 2013 |
An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma T Charles, D Quinn, M Weatherall, S Aldington, R Beasley, S Holt Journal of Allergy and Clinical Immunology 119 (4), 811-816, 2007 | 198 | 2007 |
Design and baseline characteristics of participants in the R esearching cardiovascular E vents with a W eekly IN cretin in D iabetes (REWIND) trial on the cardiovascular … HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... Diabetes, Obesity and Metabolism 20 (1), 42-49, 2018 | 196 | 2018 |
Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma M Masoli, M Weatherall, S Holt, R Beasley Thorax 60 (9), 730-734, 2005 | 161 | 2005 |
Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis M Masoli, S Holt, M Weatherall, R Beasley European Respiratory Journal 23 (4), 552-558, 2004 | 115 | 2004 |
Clinical dose-response relationship of fluticasone propionate in adults with asthma M Masoli, M Weatherall, S Holt, R Beasley Thorax 59 (1), 16-20, 2004 | 115 | 2004 |
Accuracy of references in five leading medical journals R Siebers, S Holt The Lancet 356 (9239), 1445, 2000 | 110 | 2000 |
Global Burden of Asthma, Developed for the Global Initiative for Asthma (GINA) M Masoli, D Fabian, S Holt, R Beasley Allergy 59, 469-478, 2004 | 92 | 2004 |
The burden of asthma in New Zealand S Holt, R Beasley Asthma and Respiratory Foundation of New Zealand, 2002 | 74 | 2002 |
Systematic review of the dose-response relation of inhaled fluticasone propionate M Masoli, M Weatherall, S Holt, R Beasley Archives of disease in childhood 89 (10), 902-907, 2004 | 66 | 2004 |
Efficacy of bupropion in the indigenous Maori population in New Zealand S Holt, C Timu-Parata, S Ryder-Lewis, M Weatherall, R Beasley Thorax 60 (2), 120-123, 2005 | 58 | 2005 |
Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis M Masoli, M Weatherall, S Holt, P Shirtcliffe, R Beasley European Respiratory Journal 28 (5), 960-967, 2006 | 56 | 2006 |
Global initiative for asthma (GINA) program M Masoli, D Fabian, S Holt, R Beasley The global burden of asthma 2004, 59, 2004 | 53 | 2004 |
Budesonide once versus twice‐daily administration: meta‐analysis M Masoli, M Weatherall, S Holt, R Beasley Respirology 9 (4), 528-534, 2004 | 52 | 2004 |
Asthma morbidity, control and treatment in New Zealand: results of the Patient Outcomes Management Survey (POMS), 2001 S Holt, M Kljakovic, J Reid, POMS Steering Committee New Zealand Medical Association, 2003 | 48 | 2003 |
The use of the self-management plan system of care in adult asthma S Holt, M Masoli, R Beasley Primary Care Respiratory Journal 13 (1), 19-27, 2004 | 39 | 2004 |